|
Status |
Public on Aug 25, 2017 |
Title |
CUTLL Lanatoside C rep 2 |
Sample type |
RNA |
|
|
Source name |
CUTLL Cell Line
|
Organism |
Homo sapiens |
Characteristics |
cell line: CUTLL1 tissue: TALL Leukemia treatment: Lanatoside C 24h
|
Treatment protocol |
CUTLL1 cells were treated with Withaferin A or DMSO for 24 hours.
|
Growth protocol |
CUTLL1 cells were cultured in standard conditions in RPMI 1640 media supplemented with 10% FBS and 1% Penicillin/Streptomycin
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA isolation from cell lines was performed in 6 replicates using the RNeasy Micro kit (QIAGEN) according to manufacturer’s protocol.
|
Label |
biotin
|
Label protocol |
10 ng of RNA from each sample was amplified using the Ovation PicoSL WTA System (NuGen), labeled by the Encore BiotinIL Module (NuGen)
|
|
|
Hybridization protocol |
hybridized to the Illumina HumanT-12v4 Expression BeadChip Expression BeadChip according to manufacturer’s protocol
|
Scan protocol |
Standard scan according to manufacturer's protocol
|
Description |
replicate 2
|
Data processing |
Raw gene expression data were log2 transformed and quantile-normalized using MATLAB.
|
|
|
Submission date |
Feb 23, 2016 |
Last update date |
Aug 25, 2017 |
Contact name |
Alberto Ambesi-Impiombato |
Organization name |
Columbia University
|
Department |
ICG
|
Street address |
1130 St. Nicholas Avenue
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10032 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (2) |
GSE78188 |
Gene expression profiling of CUTLL cell lines upon 17 drug treatments |
GSE78189 |
Synergistic antileukemic therapies in NOTCH-induced T-ALL |
|